CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8(+)CD103(+) cDC1 and TRM cell responses
CD40激动剂通过促进意想不到的CD8(+)CD103(+) cDC1和TRM细胞反应,提高了不可逆电穿孔消融治疗转移性黑色素瘤的疗效。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04217-7
Wu, Zhaojia; Yang, Zhenyu; Iftikhar, Tauqeer; Groot, Gary; Leary, Scot C; Baniak, Nicolas; Ahmed, Shahid; Bosch, Mark; Moser, Michael; Zhang, Wenjun; Jiang, Junhong; Xiang, Jim
黑色素瘤
T细胞
CD103
CD8
CD40
CD10
细胞生物学
CD4